Increase text size: A A A

Type in the condition you need,
or visit Advanced Search

Print this page

Email this to a friend

Comment on this page

Save to my Health Library

Johns Hopkins Health Alert

Common GERD Drug Increases Risk of Osteoporosis

This Health Alert is intended for readers interested in learning about the prevention, diagnosis, and management of osteoporosis.

Proton pump inhibitors (PPIs) treat GERD and ulcers by limiting the production of caustic gastric acids. The problem: Gastric acids are a vital component of digestion. Blocking them may interfere with the absorption of calcium, which is essential for maintaining strong bones. By limiting calcium absorption, PPIs may put you at greater risk for developing osteoporosis. If you have osteoporosis, taking a PPI may increase your fracture risk. Here’s what you need to know …

A recent study published in the Canadian Medical Association Journal compared 15,792 people with osteoporosis who fractured a wrist, vertebra, or hip with 47,289 people who didn't have osteoporosis or a previous fracture. The researchers found that taking a PPI at least every other day turned out to be substantially more common in the osteoporosis/fracture group. In particular, people who reported using PPIs for seven years or more were four times as likely to fracture a bone. Taking PPIs for less than five years was safe, but after that, risk increased.

What does this mean for you? While doctors are taking this information seriously, it is important to note that the data come from an observational trial that followed participants over a number of years, recording and comparing their medical information. Placebo-controlled clinical trials -- the gold standard of medical proof -- have yet to test the link between PPIs and osteoporosis.

H. Franklin Herlong, M.D., Associate Professor of Medicine, Division of Gastroenterology, Johns Hopkins Bayview Medical Center, and Health After 50 Board Member, remarks, "The new information should encourage doctors to review the need for long-term PPI use and ensure the benefits continue to outweigh the potential risk.

"I'm concerned about the long-term use of PPIs, particularly for patients who have or are at increased risk for osteoporosis and people with conditions such as liver disease that interfere with their ability to utilize vitamin D and calcium. "These patients should have bone density tests and, if the tests show evidence of osteoporosis, take calcium and vitamin D supplements while continuing their PPI."

Proton Pump Inhibitors

  • Omeprazole (Losec, Prilosec, Zegerid, Ocid)
  • Lansaprazole (Prevacid, Zoton, Inhibitol)
  • Esomeprazole (Nexium)
  • Pantoprazole (Protonix, Somac, Pantoloc, Pantozol, Zurcal, PAN)
  • Rabeprazole (Rabecid, Aciphex, Pariet, Rabeloc)
  • Prilosec OTC (available without a prescription)

Posted in Back Pain and Osteoporosis on January 15, 2010

Notify Me

Would you like us to inform you when we post new Back Pain and Osteoporosis Health Alerts?

Your Email Address:

Comments

Post a Comment

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or MediZine LLC, which has no responsibility for any comments posted on this site.




Post a Comment


Already a subscriber?
Login

Email:

Password:


Forgot your password?

New to Johns Hopkins Health Alerts?
Register to submit your comments.

Your Email Address:

(example: yourname@domain.com)

 

(800) 829-0422

Registered Users Log-in:

Email:

Password:

Remember me
Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being A Registered User

Health Topic Pages

Arthritis
Back Pain & Osteoporosis
Cancer
Caregivers | Caregiving
Colon Cancer
Complementary Medicine
Depression & Anxiety
Diabetes
Digestive Health
Enlarged Prostate
Exercise and Fitness
Healthy Living
Heart Health
Hypertension & Stroke
Lung Disorders
Memory
Men's Health
Nutrition
Prescription Drugs
Prostate Disorders
Sexual Health
Vision
Weight Control
Women's Health
Health Alert Special Report



Johns Hopkins’ Bestsellers

Back Pain and Osteoporosis

Johns Hopkins White Papers

  • 2010 Back Pain and Osteoporosis White Paper
    A lifetime of walking, standing, lifting, and twisting causes significant low back pain in 80% of all adults. And as our population continues to age, osteoporosis becomes an increasingly widespread problem. In the Back Pain and Osteoporosis White Paper, Johns Hopkins experts discuss sprains, strains, spasms, disk herniation, degenerative changes in the disks and spine, spinal stenosis, and osteoporosis, a common cause of hip and spine fractures. You will explore causes of back pain, learn about preventive steps and pain relief, and examine treatments that include the latest drug and surgical options. 96 pages.
    Click here to read more or order the DIGITAL DOWNLOAD

    Click here to read more or order the PRINT EDITION

  • Related Titles:




    ALL NEW!Number One of America's Best Hospitals 2010-2011: Johns Hopkins

    The Johns Hopkins Hospital has been ranked #1 again in the Honor Roll of America's Best Hospitals by
    U.S. News and World Report for the 20th consecutive year.


    Please visit here for more information about Johns Hopkins Patient Services


    © 2010 MediZine LLC. All rights reserved.
    Contact Us
    customerservice@johnshopkinshealthalerts.com